Document Type
Article
Publication Date
6-17-2024
Original Citation
Bokoliya S,
Russell J,
Dorsett Y,
Panier H,
Singh V,
Daddi L,
Yuan H,
Dedon L,
Liu Z,
Zhou Y,
Min Z,
Barson J,
Covault J,
Bubier JA,
Zhou Y.
Short-chain fatty acid valerate reduces voluntary alcohol intake in male mice. Microbiome. 2024;12(1):108.
Keywords
JMG, Animals, Male, Mice, Gastrointestinal Microbiome, gamma-Aminobutyric Acid, Fatty Acids, Volatile, Alcohol Drinking, Amygdala, Ethanol, Mice, Inbred C57BL, Disease Models, Animal, Binge Drinking, Pentanoic Acids
JAX Source
Microbiome. 2024;12(1):108.
ISSN
2049-2618
PMID
38886761
DOI
https://doi.org/10.1186/s40168-024-01829-6
Grant
J.A.B. was supported by U01 DA043809.
Abstract
BACKGROUND: Despite serious health and social consequences, effective intervention strategies for habitual alcohol binge drinking are lacking. The development of novel therapeutic and preventative approaches is highly desirable. Accumulating evidence in the past several years has established associations between the gut microbiome and microbial metabolites with drinking behavior, but druggable targets and their underlying mechanism of action are understudied.
RESULTS: Here, using a drink-in-the-dark mouse model, we identified a microbiome metabolite-based novel treatment (sodium valerate) that can reduce excessive alcohol drinking. Sodium valerate is a sodium salt of valeric acid short-chain fatty acid with a similar structure as γ-aminobutyric acid (GABA). Ten days of oral sodium valerate supplementation attenuates excessive alcohol drinking by 40%, reduces blood ethanol concentration by 53%, and improves anxiety-like or approach-avoidance behavior in male mice, without affecting overall food and water intake. Mechanistically, sodium valerate supplementation increases GABA levels across stool, blood, and amygdala. It also significantly increases H4 acetylation in the amygdala of mice. Transcriptomics analysis of the amygdala revealed that sodium valerate supplementation led to changes in gene expression associated with functional pathways including potassium voltage-gated channels, inflammation, glutamate degradation, L-DOPA degradation, and psychological behaviors. 16S microbiome profiling showed that sodium valerate supplementation shifts the gut microbiome composition and decreases microbiome-derived neuroactive compounds through GABA degradation in the gut microbiome.
CONCLUSION: Our findings suggest that sodium valerate holds promise as an innovative therapeutic avenue for the reduction of habitual binge drinking, potentially through multifaceted mechanisms.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.